RxDoctor Payments Data

Alexander Farag, MD

Otolaryngology · Jacksonville, FLNPI 1003043902

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Acclarent, Inc at 58.3% of the total. Reporting peaked in 2019 at $9,966 and has fallen 79.5% since, to $2,042 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,404in general payments, 2019–2025

Across 127 payments — averaging $121.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$9K
  • Medtronic$2K
  • Integra Lifesciences Corporation$1K
  • Regeneron Healthcare Solutions, Inc.$800
  • Inspire Medical Systems, Inc.$659
  • Sanofi$368
  • plus $1K from 16 others
$77,016in research payments, 2019–2025

Across 1 payment — averaging $77,016 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$77K

What the payments were for

  • Consulting fees$8,00052%
  • Travel & lodging$2,76118%
  • Food & beverage$4,55630%
  • Education$871%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,404 in reported general payments places this provider in the 90th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$187,084
Medicare patients
230
Services billed
1,159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate36$2,227
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$2,219
Azelastine-FluticasoneAzelastine/Fluticasone20$1,770
Omeprazole80$1,593
Ipratropium Bromide63$1,343
Azelastine Hcl27$1,054
Famotidine79$824
Fluticasone Propionate60$730
Cefdinir12$294
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$142
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$124
Prednisone13$16

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →